Literature DB >> 19963136

Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.

Gary Lu1, Yue Kong, Changjun Yue.   

Abstract

Recent studies have shown a higher frequency of immunoglobulin heavy (IGH@) locus rearrangement in B-cell chronic lymphocytic leukemia (B-CLL) than previously reported. However, association of the IGH@ rearrangement with specific chromosomal abnormalities and immunophenotypic markers in B-CLL is still under further investigation. In this study, we analyzed 149 bone marrow aspirate or peripheral blood specimens from patients diagnosed with B-CLL, evaluated by four different laboratory studies: morphology examination, three- or four-color flow cytometry analysis, conventional cytogenetics, and fluorescence in situ hybridization (FISH) with a dual-color, break-apart IGH@ probe in addition to a B-CLL FISH probe panel for del(11)(q22) ATM, del(13)(q14.3), del(17)(p13) TP53, and +12. An IGH@ rearrangement was found by FISH in 24 cases (16.0%). Of these 24 cases, 16 (67%) contained chromosomal abnormalities, including t(14;19)(q32;q13.2), t(8;14)(q24;q32), and t(14;18)(q32;q21). In addition, a cryptic deletion of the immunoglobulin heavy variable region (IGHV) was revealed. Using 30% as the cutoff for positive CD38 expression, 22 of the 24 cases (92%) were positive for CD38. The present results further confirm that IGH@ rearrangement is not a rare genomic abnormality in B-CLL, and also show both that t(14;19)(q32;q13.2) is the most common cytogenetic change involving IGH@ rearrangement detected by FISH in B-CLL and that IGH@ rearrangement is correlated with CD38 expression. It is appropriate to include an IGH@ probe in the FISH panel for B-CLL diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19963136     DOI: 10.1016/j.cancergencyto.2009.08.021

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.

Authors:  L Yang; H Wang; S M Kornblau; D A Graber; N Zhang; J A Matthews; M Wang; D M Weber; S K Thomas; J J Shah; L Zhang; G Lu; M Zhao; R Muddasani; S-Y Yoo; K A Baggerly; R Z Orlowski
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

2.  Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.

Authors:  Gary Lu; Ramya Muddasani; Robert Z Orlowski; Lynne V Abruzzo; Muzaffar H Qazilbash; M James You; Yaping Wang; Ming Zhao; Su Chen; Isabella Claudia Glitza; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2013-05       Impact factor: 5.534

3.  IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xiao Mao; Min Xiao; Ying Wang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

4.  Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

Authors:  Marc DE Braekeleer; Corine Tous; Nadia Guéganic; Marie-Josée LE Bris; Audrey Basinko; Frédéric Morel; Nathalie Douet-Guilbert
Journal:  Mol Clin Oncol       Date:  2016-02-26

5.  Chronic lymphocytic leukemia with t(14;18)(q32;q21).

Authors:  Guilin Tang; Haley E Banks; Rachel L Sargent; L Jeffrey Medeiros; Lynne V Abruzzo
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

6.  t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.

Authors:  Weifeng Chen; Yi Miao; Rong Wang; Yujie Wu; Hairong Qiu; Wei Xu; Jianyong Li; Lei Fan; Xin Xu
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

7.  Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH/BCL3 Rearrangements: Report of Three Chinese Cases and Literature Review.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xia Mao; Min Xiao; Jia Wei; Ying Wang
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

Review 8.  The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment.

Authors:  Claudia Pérez-Carretero; Isabel González-Gascón-Y-Marín; Ana E Rodríguez-Vicente; Miguel Quijada-Álamo; José-Ángel Hernández-Rivas; María Hernández-Sánchez; Jesús María Hernández-Rivas
Journal:  Diagnostics (Basel)       Date:  2021-05-10

9.  Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.

Authors:  Ina Amarillo; Peter H Bui; Sibel Kantarci; Nagesh Rao; Brit S Shackley; Rolando García; Carlos A Tirado
Journal:  Mol Cytogenet       Date:  2013-02-01       Impact factor: 2.009

10.  Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality.

Authors:  Ghaleb Elyamany; Kamal Fadalla; Hatem Elghezal; Omar Alsuhaibani; Hani Osman; Abdulaziz Al-Abulaaly
Journal:  Clin Med Insights Pathol       Date:  2014-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.